Solving another piece of the thrombotic thrombocytopenic purpura puzzle? [PDF]
Evangelidis P, Gavriilaki E.
europepmc +1 more source
The impact of caplacizumab in the treatment of immune thrombotic thrombocytopenic purpura. A retrospective monocentric cohort study. [PDF]
Markovic U +16 more
europepmc +1 more source
Hereditary Thrombotic Thrombocytopenic Purpura Associated With Recurrent Strokes and Prominent Nervous System Involvement in a Young Chinese Female. [PDF]
Liu W +10 more
europepmc +1 more source
Comment on "Fulminant Myocarditis in Immune-Mediated Thrombotic Thrombocytopenic Purpura: A Case Report". [PDF]
Satapathy P, Mehta R, Sah R.
europepmc +1 more source
Risk factors for hypotension and technical complications during single-session double-filtration plasmapheresis: a 15-year retrospective study of 1,022 procedures. [PDF]
Gao C +8 more
europepmc +1 more source
Daratumumab for relapsed refractory immune thrombotic thrombocytopenic purpura: initial response and long-term follow-up. [PDF]
Schimmer R +6 more
europepmc +1 more source
N-Acetylcysteine Therapy in Thrombotic Thrombocytopenic Purpura: A Systematic Review and Critical Appraisal. [PDF]
Demirci U, Bilgin ZT, Baysal M.
europepmc +1 more source
Epidemiology, therapy, and outcome of immune-mediated thrombotic thrombocytopenic purpura at population level in Germany. [PDF]
Scharenberg AY +9 more
europepmc +1 more source
Thrombotic thrombocytopenic purpura as a complication of pembrolizumab: a case report and literature Review. [PDF]
Palega G +3 more
europepmc +1 more source

